Cite
Cardiovascular risk in pulmonary alveolar proteinosis.
MLA
Manali, Effrosyni D., et al. “Cardiovascular Risk in Pulmonary Alveolar Proteinosis.” Expert Review of Respiratory Medicine, vol. 10, no. 2, Feb. 2016, pp. 235–40. EBSCOhost, https://doi.org/10.1586/17476348.2016.1116389.
APA
Manali, E. D., Papadaki, G., Konstantonis, D., Tsangaris, I., Papaioannou, A. I., Kolilekas, L., Schams, A., Kagouridis, K., Karakatsani, A., Orfanos, S., Griese, M., & Papiris, S. A. (2016). Cardiovascular risk in pulmonary alveolar proteinosis. Expert Review of Respiratory Medicine, 10(2), 235–240. https://doi.org/10.1586/17476348.2016.1116389
Chicago
Manali, Effrosyni D., Georgia Papadaki, Dimitrios Konstantonis, Iraklis Tsangaris, Andriana I. Papaioannou, Likurgos Kolilekas, Andrea Schams, et al. 2016. “Cardiovascular Risk in Pulmonary Alveolar Proteinosis.” Expert Review of Respiratory Medicine 10 (2): 235–40. doi:10.1586/17476348.2016.1116389.